Founded Year

2016

Stage

Series C - II | Alive

Total Raised

$60.99M

About Qure.ai

Qure.ai has developed an artificial intelligence-based system to identify abnormalities in head CT scans. The company aims to leverage deep learning effectively to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. It was founded in 2016 and is based in Mumbai, India.

Qure.ai Headquarters Location

Level 6, Oberoi Commerz II, Goregaon East

Mumbai, 400063,

India

+91 22 4067 5800

Qure.ai's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Qure.ai's Products & Differentiation

See Qure.ai's products and how their products differentiate from alternatives and competitors

  • qXR

    can detect abnormal findings on a chest X-ray. Its is a CE-certified patented algorithms that can detect a total of 30 findings on the chest X-ray.

    Differentiation

    qXR has a sensitivity and specificity equivalent to expert radiologists. It can 

    assist radiologists by clustering their worklists into distinct buckets of Normal, Abnormal and To Be Reviewed. 

    It can also automate reporting with precise findings and quantification. It Is a great aid to manage long worklists, enhance reporting speed and prioritize cases that need immediate attention. 

    Key Value Deliverables 

    Seamlessly integrates with worklists across different PACS systems for reassignment & escalation. 

    Vendor agnostic integration. 

    Key Features 

    One of the Largest training dataset 

    Underlying convolutional neural networks trained with >5 Million scans, generalize well to new data. Clinically validated in multiple geographies. 

    Supports analog X-rays 

    Tested with X-rays from all major manufacturers (DR and CR) 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Qure.ai

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Qure.ai is included in 7 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

11,738 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health 150

300 items

The winners of the second annual CB Insights Digital Health 150.

D

Digital Hospital

198 items

Startups recreating how healthcare is delivered

D

Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

10,541 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

Qure.ai Patents

Qure.ai has filed 10 patents.

The 3 most popular patent topics include:

  • Artificial neural networks
  • Medical imaging
  • Machine learning
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/3/2021

6/21/2022

Image processing, Medical imaging, Deep learning, Artificial neural networks, Artificial intelligence

Grant

Application Date

12/3/2021

Grant Date

6/21/2022

Title

Related Topics

Image processing, Medical imaging, Deep learning, Artificial neural networks, Artificial intelligence

Status

Grant

Latest Qure.ai News

Fujifilm and Qure.ai Join Hands With IHVN to Accelerate TB Screening in Rural Nigerian Communities

Aug 12, 2022

- Fujifilm’s Xair ultra-portable handheld, battery powered X-ray machine will be deployed with Qure.ai’s AI-enabled Chest X-ray solution to screen presumptive TB cases - The partnership is aimed at augmenting active screening for TB in hotspots with the support of USAID and the Lagos State TB program. August 12, 2022 04:07 AM Eastern Daylight Time LAGOS, Nigeria--( BUSINESS WIRE )--The Institute of Human Virology in Nigeria (IHVN) has announced their partnership with Fujifilm, the multinational medical imaging device manufacturers and Qure.ai, a global AI-enabled medical imaging solutions provider to use advanced technology to help optimize tuberculosis (TB) screening outreach in Nigeria. The partnership has enabled USAID funded IHVN to deploy ultra-portable X-ray machines embedded with AI for active case finding in Nigerian rural communities. TB is the leading cause of death in Sub-Saharan Africa (Nigeria inclusive) and the most common opportunistic co-infection alongside HIV. Fujifilm’s Xair portable Xray device powered by the Qure.ai artificial intelligence algorithms provide an ideal solution for the rural mass testing programs, offering ultra-portability, high accuracy and efficiency point of care diagnostic solutions. Dr. Chukwuma Anyaike, Director and National Coordinator, National Tuberculosis, Leprosy and Buruli Ulcer Control Program - Federal Ministry of Health NIGERIA, said, "The successful piloting of the use of portable digital x-ray from Fujifilm with Qure.ai technology by IHVN in collaboration with NTBLCP, Federal Ministry of Health Nigeria has proven its positive impact on case detection of tuberculosis." Commenting on the partnership, Dr Aderonke Agbaje, Chief of Party USAID TB-LON 3 Project at Institute of Human Virology Nigeria, said, “IHVN is at the forefront of battling TB and correlated infections using innovative solutions to optimise care delivery. Through our efforts (rural dwellers in communities with difficult terrains have been reached with TB care). Our partnership with Fujifilm and Qure.ai for AI enabled TB screening is our most recent initiatives towards community outreach. We look forward to scaling active case finding efforts and improving patient care." The United States Agency for International Development (USAID) is working with IHVN to rapidly increase the level of TB cases detected and treated in Nigeria over the next five years. The project aims to improve access to high-quality, patient-centric treatment for TB, including drug-resistant tuberculosis and co-infections with HIV, which is common in the community. The project also covers contact tracing of TB presumptive cases to curb contagion and bring more cases under the aegis of the national TB reporting system. IHVN is the implementing partner for the project that covers the states of Lagos, Osun, Ogun, and Oyo. Commenting on the development, Godspower Asika, National Sales Manager – Nigeria, Fujifilm Middle East & Africa, said, “We are happy to note that IHVN is screening numerous communities in Nigeria with our ultra-portable x-ray machine, the Fujifilm FDR Xair, which is integrated with AI technology from Qure.ai. We applaud the Federal Ministry of Health of Nigeria's NTBLCP leadership for working kindly with IHVN to accomplish this, and Fujifilm will continue to make its technology available to all partners and stakeholders.” Fujifilm FDR Xair is a battery-powered, ultralight, and compact X-ray device that can function for hours without electricity. FDR Xair, coupled with Qure.ai’s Al-powered radiological image analysis allows for accurate screening & detection of lung abnormalities, and presumptive TB even in the remotest parts of the world and can be beneficial in expediting the process of TB diagnosis at the point of care. Commenting on the partnership, Prashant Warier, CEO and Founder, Qure.ai said, “We are excited to partner with Fujifilm on this project to combine two state-of-the-art technologies for the greater communal good. Our AI enabled chest X-ray solution, qXR, has been evaluated by WHO and meets their criteria for TB triage and screening in the absence of a human reader. IHVN’s Nigeria project will help reinforce what superior technology can do for universal lung health and healthcare access for everyone.” Qure.ai's chest X-ray software can detect multiple lung abnormalities within a minute. It can accurately assess radiological findings suggestive of a host of diseases, including pneumonia, COPD, TB, and Heart Failure, among others. Together IHVN, Fujifilm and Qure.ai aim to strengthen the systems and structures for tuberculosis detection, treatment, and notification in rural Nigeria. The partnership will help in reducing the transmission and progression of tuberculosis and aid in accelerating tuberculosis research and innovation to improve the quality of programs implemented. Contacts

Qure.ai Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Qure.ai Rank

  • When was Qure.ai founded?

    Qure.ai was founded in 2016.

  • Where is Qure.ai's headquarters?

    Qure.ai's headquarters is located at Level 6, Oberoi Commerz II, Goregaon East, Mumbai.

  • What is Qure.ai's latest funding round?

    Qure.ai's latest funding round is Series C - II.

  • How much did Qure.ai raise?

    Qure.ai raised a total of $60.99M.

  • Who are the investors of Qure.ai?

    Investors of Qure.ai include Merck & Co., MassMutual Ventures, Novo Holdings, Healthquad, SBRI Healthcare and 6 more.

  • Who are Qure.ai's competitors?

    Competitors of Qure.ai include Lunit, Aidoc Medical, Deeptek, QUIBIM, Zebra Medical Vision, VUNO, InMed Prognostics, mediaire, Kheiron Medical Technologies, Blue Eye Soft and 13 more.

  • What products does Qure.ai offer?

    Qure.ai's products include qXR and 3 more.

  • Who are Qure.ai's customers?

    Customers of Qure.ai include NHS Trusts and vRAD.

You May Also Like

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics Logo
Ultromics

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Enlitic Logo
Enlitic

Enlitic develops a diagnosis system that uses deep learning to analyze medical data in order to enable quick and more accurate detection of diseases that can be identified through medical images such as X-rays and CT scans.

Koios Medical Logo
Koios Medical

Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics. Koios Medical was formerly known as Clearview Diagnostics. The company was founded in 2012 and is based in Chicago, Illinois.

K
Kheiron Medical Technologies

Kheiron Medical Technologies is a healthcare software company. Through its Machine Learning technology, it seeks to makes cancer diagnoses faster, easier, cheaper and more accurate. Its Deep Learning algorithms analyze medical images and its software uses the analysis results to enable the automation of radiology reporting tasks.

Infervision Logo
Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.